...
首页> 外文期刊>Journal of Pharmacy and Pharmacology >Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
【24h】

Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.

机译:人类药代动力学的预测-改进基于微粒体的肝代谢清除率预测。

获取原文
获取原文并翻译 | 示例
           

摘要

Physiologically based methods generally perform poorly in predicting in-vivo hepatic CL (CL(H)) from intrinsic clearance (CL(int)) in microsomes in-vitro and unbound fraction in blood (f(u,bl)). Various strategies to improve the predictability have been developed, and inclusion of an empirical scaling factor (SF) seems to give the best results. This investigation was undertaken to evaluate this methodology and to find ways to improve it further. The work was based on a diverse data set taken from Ito and Houston (2005). Another objective was to evaluate whether rationalization of CL(H) predictions can be made by replacing blood/plasma-concentration ratio (C(bl)/C(pl)) measurements with SFs. There were apparently no or weak correlations between prediction errors and lipophilicity, permeability (compounds with low permeability missing in the data set) and main metabolizing CYP450s. The use of CL(int) class (high/low) and drug class (acid/baseeutral) SFs (the CD-SF method) gives improved and reasonable predictions: 1.3-fold median error (an accurate prediction has a 1-fold error), 76% within 2-fold-error, and a median absolute rank ordering error of 2 for CL(H) (n = 29). This approach is better than the method with a single SF. Mean (P < 0.05) and median errors, fraction within certain error ranges, higher percentage with most accurate predictions, and ranking were all better, and 76% of predictions were more accurate with this new method. Results are particularly good for bases, which generally have higher CL(H) and the potential to be incorrectly selected/rejected as candidate drugs. Reasonable predictions of f(u,bl) can be made from plasma f(u) (f(u,pl)) and empirical blood cell binding SFs (B-SFs; 1 for low f(u,pl) acids; 0.62 for other substances). Mean and median f(u,bl) prediction errors are negligible. The use of the CD-SF method with predicted f(u,bl) (the BCD-SF method) also gives improved and reasonable results (1.4-fold median error; 66% within 2-fold-error; median absolute rank ordering error =1). This new empirical approach seems sufficiently good for use during the early screening; it gives reasonable estimates of CL(H) and good ranking, which allows replacement of C(bl)/C(pl) measurements by a simple equation.
机译:基于生理的方法通常无法从微粒体内的固有清除率(CL(int))和血液中的未结合部分(f(u,bl))预测体内肝CL(CL(H))。已经开发出各种改善可预测性的策略,并且包括经验比例因子(SF)似乎能提供最佳结果。进行这项调查是为了评估这种方法并找到进一步改进它的方法。这项工作是基于从伊藤和休斯顿(2005)收集的各种数据集。另一个目的是评估是否可以通过用SF代替血液/血浆浓度比(C(bl)/ C(pl))测量值来使CL(H)预测合理化。预测误差与亲脂性,通透性(数据集中缺少低通透性的化合物)和主要代谢CYP450之间似乎没有相关性或相关性很弱。使用CL(int)级(高/低)和药物级(酸/碱/中性)SF(CD-SF方法)可提供改进和合理的预测:中位数误差为1.3倍(准确的预测为1倍误差),2倍误差内的误差为76%,CL(H)的平均绝对秩排序误差为2(n = 29)。此方法比使用单个SF的方法更好。平均值(P <0.05)和中位数误差,在一定误差范围内的分数,具有最准确的预测的百分比更高,排名都更高,并且使用此新方法的预测占76%的精度更高。结果对于碱基而言尤其好,碱基通常具有较高的CL(H),而且可能被错误地选择/拒绝作为候选药物。 f(u,bl)的合理预测可从血浆f(u)(f(u,pl))和经验血细胞结合SF(B-SFs;低f(u,pl)酸为1; 0.62为f)其他物质)。均值和中值f(u,bl)预测误差可忽略不计。将CD-SF方法与预测的f(u,bl)结合使用(BCD-SF方法)还可以提供改进且合理的结果(1.4倍中位数误差; 2倍误差内的误差为66%;中位数绝对秩排序误差) = 1)。这种新的经验方法似乎足以用于早期筛查。它给出了合理的CL(H)估计值和良好的排名,从而可以用一个简单的方程式替换C(bl)/ C(pl)测量值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号